Vident Advisory’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.57M | Buy |
68,295
+28,788
| +73% | +$3.19M | 0.09% | 199 |
|
|
2025
Q1 | $4.43M | Buy |
39,507
+13,679
| +53% | +$1.53M | 0.06% | 263 |
|
|
2024
Q4 | $2.39M | Sell |
25,828
-29,112
| -53% | -$2.69M | 0.04% | 375 |
|
|
2024
Q3 | $4.61M | Buy |
54,940
+24,824
| +82% | +$2.08M | 0.12% | 166 |
|
|
2024
Q2 | $2.07M | Sell |
30,116
-9,748
| -24% | -$669K | 0.06% | 357 |
|
|
2024
Q1 | $2.92M | Sell |
39,864
-69,227
| -63% | -$5.07M | 0.06% | 301 |
|
|
2023
Q4 | $8.84M | Buy |
109,091
+1,266
| +1% | +$103K | 0.22% | 143 |
|
|
2023
Q3 | $8.08M | Buy |
+107,825
| New | +$8.08M | 0.25% | 131 |
|